Table of Contents
Leukemia Research and Treatment
Volume 2012, Article ID 932175, 8 pages
Review Article

Clinical Trials of Adult T-Cell Leukaemia/Lymphoma Treatment

1Department of Hematology, Necker Hospital, 75473 Paris Cedex 15, France
2Department of Internal Medicine, American University of Beirut, Beirut, Lebanon

Received 5 October 2011; Accepted 11 November 2011

Academic Editor: Kunihiro Tsukasaki

Copyright © 2012 Ambroise Marçais et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [8 citations]

The following is the list of published articles that have cited the current article.

  • Risaku Fukumoto, “Human T-lymphotropic virus type 1 non-structural proteins: Requirements for latent infection,” Cancer Science, vol. 104, no. 8, pp. 983–988, 2013. View at Publisher · View at Google Scholar
  • Ambroise Marcais, Felipe Suarez, David Sibon, Laurent Frenzel, and Ali Bazarbachi, “Therapeutic Options for Adult T-Cell Leukemia/Lymphoma,” Current Oncology Reports, vol. 15, no. 5, pp. 457–464, 2013. View at Publisher · View at Google Scholar
  • Martin Miguel Amor, Aedan Simon Olaso, Robert Atienza, Benjamin Stueben, Seth Cohen, and Plamen Kossev, “Adult T-Cell Leukemia-Lymphoma during Pregnancy,” Case Reports in Oncological Medicine, vol. 2013, pp. 1–3, 2013. View at Publisher · View at Google Scholar
  • David Olagnier, Alexandre Sze, Samar Bel Hadj, Cindy Chiang, Courtney Steel, Xiaoying Han, Jean-Pierre Routy, Rongtuan Lin, John Hiscott, and Julien van Grevenynghe, “HTLV-1 Tax-Mediated Inhibition of FOXO3a Activity Is Critical for the Persistence of Terminally Differentiated CD4(+) T Cells,” Plos Pathogens, vol. 10, no. 12, 2014. View at Publisher · View at Google Scholar
  • A. Bazarbachi, K. Cwynarski, A. Boumendil, H. Finel, P. Fields, K. Raj, A. Nagler, M. Mohty, A. Sureda, P. Dreger, and O. Hermine, “Outcome of patients with HTLV-1-associated adult T-cell leukemia/lymphoma after SCT: a retrospective study by the EBMT LWP,” Bone Marrow Transplantation, vol. 49, no. 10, pp. 1266–1268, 2014. View at Publisher · View at Google Scholar
  • Meili Zhang, Lesley A. Mathews Griner, Wei Ju, Damien Y. Duveau, Rajarshi Guha, Michael N. Petrus, Bernard Wen, Michiyuki Maeda, Paul Shinn, Marc Ferrer, Kevin D. Conlon, Richard N. Bamford, John J. O'Shea, Craig J. Thomas, and Thomas A. Waldmann, “Selective targeting of JAK/STAT signaling is potentiated by Bcl-xL blockade in IL-2-dependent adult T-cell leukemia,” Proceedings Of The National Academy Of Sciences Of The United States Of America, vol. 112, no. 40, pp. 12480–12485, 2015. View at Publisher · View at Google Scholar
  • Adrienne Alise Phillips, “Hematopoeitic stem cell transplantation for adult T cell leukemia-lymphoma: Who is the best candidate?,” Leukemia & Lymphoma, pp. 1–3, 2016. View at Publisher · View at Google Scholar
  • Uyen Ngoc Mui, Christopher Haley, and Stephen K. Tyring, “Viral Oncology: Molecular Biology and Pathogenesis,” Journal of Clinical Medicine, vol. 6, no. 12, pp. 111, 2017. View at Publisher · View at Google Scholar